Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHSE: 600572)
Health Care · Pharmaceuticals · CN
CN¥4.32
-10.00% today · -7.5% 1Y
Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHSE: 600572) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.63B and employs 7,826 people.
Over the last twelve months the share price has lost 7.5%, trading between 3.77 and 5.17.
Tweenvest scores Zhejiang CONBA Pharmaceutical Co.,Ltd. across four factors: quality 83/100, value 54/100, growth 13/100, dividend 85/100. Its strongest factor is dividend.
600572 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.63B
- Revenue (TTM)
- $970.53M
- P/E
- 22.35
- EPS
- 0.19
- Dividend yield
- 3.47%
- Beta (5Y)
- 0.21
- 52-week high
- CN¥5.17
- 52-week low
- CN¥3.77
- Avg volume (3M)
- —
- Shares outstanding
- 2.54B
- Employees
- 7,826
- Next earnings
- —
About Zhejiang CONBA Pharmaceutical Co.,Ltd.
Zhejiang CONBA Pharmaceutical Co., Ltd., a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd., is headquartered in Hangzhou, China. Established in 1969, and formerly known as Lanxi Yunshan Pharmaceutical Factory until its name change in October 1999, the company specializes in the research, development, manufacturing, and distribution of traditional Chinese medicines and botanical products across China. Its broad portfolio extends to include chemical pharmaceuticals, proprietary Chinese medicines, vision care products, dietary supplements, general health supplies, everyday wellness goods, food items, and various personal care products.
- ISIN
- CNE000001H86
- Founded
- 1969
- Listed since
- Apr 12, 2004
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.